116 related articles for article (PubMed ID: 6172500)
1. Immortalization of antigen specific, helper T cell lines by transformation with the radiation leukemia virus (RadLV).
Yefenof E; Azar Y; Eidelsztein P; Ben-Sasson SZ
J Immunol; 1982 Feb; 128(2):625-8. PubMed ID: 6172500
[TBL] [Abstract][Full Text] [Related]
2. Induction of murine T cell lymphoma expressing specific cytotoxic activity.
Schaaf-Lafontaine N; Martin MT; Boniver J
Eur J Immunol; 1986 Mar; 16(3):320-3. PubMed ID: 3007167
[TBL] [Abstract][Full Text] [Related]
3. T helper cells change their Lyt-1,2 phenotype during an immune response.
Thomas DB; Calderon RA
Eur J Immunol; 1982 Jan; 12(1):16-23. PubMed ID: 6174347
[TBL] [Abstract][Full Text] [Related]
4. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
5. Functional properties of Ly 11.2 lymphocytes: a role for these cells in leukemia?
Meruelo D; Paolino A; Flieger N; Dworkin J; Offer M; Hirayama N; Ovary Z
J Immunol; 1980 Dec; 125(6):2719-26. PubMed ID: 6253569
[TBL] [Abstract][Full Text] [Related]
6. Production of antigen-specific suppressive T cell factor by radiation leukemia virus-transformed suppressor T cells.
Ricciardi-Castagnoli P; Doria G; Adorini L
Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3804-8. PubMed ID: 6267605
[TBL] [Abstract][Full Text] [Related]
7. T helper cells in immune mice amplify the primary anti-tumor cytotoxic response.
Yu AS; Bernstein ID
J Immunol; 1982 Aug; 129(2):856-9. PubMed ID: 6177788
[TBL] [Abstract][Full Text] [Related]
8. Ly 11.2: a cell surface antigen that may identify murine lymphocytes susceptible to transformation by oncogenic agents.
Meruelo D; Paolino A; Flieger N; Offer M; Dworkin J
Fed Proc; 1981 Oct; 40(12):2717-20. PubMed ID: 6269904
[No Abstract] [Full Text] [Related]
9. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
Liew FY; Howard JG; Hale C
J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
[TBL] [Abstract][Full Text] [Related]
11. Detection of Salmonella-specific L3T4+ and Lyt-2+ T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity.
Pope M; Kotlarski I
Immunology; 1994 Feb; 81(2):183-91. PubMed ID: 7512525
[TBL] [Abstract][Full Text] [Related]
12. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors.
Barry RA; Hinrichs DJ
Clin Invest Med; 1984; 7(4):303-9. PubMed ID: 6442653
[TBL] [Abstract][Full Text] [Related]
14. Induction, establishment in vitro, and characterization of functional, antigen-specific, carrier-primed murine T-cell lymphomas.
Finn OJ; Boniver J; Kaplan HS
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4033-7. PubMed ID: 91171
[TBL] [Abstract][Full Text] [Related]
15. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
16. In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
Yefenof E; Meidav A; Kedar E
J Exp Med; 1980 Dec; 152(6):1473-83. PubMed ID: 6256461
[TBL] [Abstract][Full Text] [Related]
17. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
18. Radiation leukemia virus: a marker for the study of intrathymic T cell differentiation.
Boniver J; Delvenne C; Janowski M; Courtoy R; Defresne MP
Thymus; 1989; 14(1-3):109-13. PubMed ID: 2560269
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced murine leukemia ERLD in cell culture.
Albrecht AM; Biedler JL; Hutchison DJ; Spengler BA; Stockert E
Cancer Res; 1976 Oct; 36(10):3784-8. PubMed ID: 1066184
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
